Breaking News, Financial News

Financial Report: Quintiles

Product Development revenues up 9% in the quarter

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Quintiles 1Q Revenues: $1.3 billion (+6%) 1Q Earnings: $90.2 million  (+87%) Comments: Product Development revenues grew 9% to $770.8 million, with growth in core clinical services in North America, clinical trial support services, and increases in global labs, and the Novella acquisition in 2013. Integrated Healthcare Service revenues were up 8% to $234.5 million, primarily due to increases in Japan and North America, as well as growth in real-world and late phase research services. Net new ...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters